logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Rhinitis Vasomotor

    FiltersReset Filters
    22 results

    • azelastine

      (Azelastine)
      Ascend Laboratories, LLC
      Usage: Azelastine HCl Nasal Spray is indicated for treating symptoms of seasonal allergic rhinitis in adults and children 5 years and older, as well as vasomotor rhinitis symptoms in adults and adolescents aged 12 years and older.

    • azelastine hydrochloride

      (Azelastine)
      AvKARE
      Usage: Azelastine hydrochloride nasal spray, 0.1%, is indicated for treating symptoms of seasonal allergic rhinitis in individuals 5 years and older, and for vasomotor rhinitis in those 12 years and older.

    • azelastine hydrochloride

      (AZELASTINE HYDROCHLORIDE)
      Aurobindo Pharma Limited
      Usage: Azelastine hydrochloride Nasal Spray is indicated for treating seasonal allergic rhinitis in adults and children aged 5 and older, as well as vasomotor rhinitis in adults and adolescents aged 12 and older.

    • brisdelle

      (paroxetine)
      Legacy Pharma USA, Inc.
      Usage: BRISDELLE is indicated for treating moderate to severe vasomotor symptoms associated with menopause. It is not approved for psychiatric conditions, and its lower dosage for menopause is not established for any psychiatric use. Patients needing paroxetine for psychiatric issues should switch to a suitable paroxetine product.

    • carbinoxamine maleate

      (CARBINOXAMINE MALEATE)
      BluCrest Pharmaceuticals, LLC
      Usage: Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin manifestations, dermatographism, and as an adjunctive therapy for anaphylactic reactions and allergic reactions to blood or plasma.

    • carbinoxamine maleate

      (Carbinoxamine Maleate)
      Biocomp Pharma, Inc.
      Usage: Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, dermatographism, as adjunct therapy for anaphylactic reactions, and to reduce the severity of allergic reactions to blood or plasma.

    • climara

      (Estradiol)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, hypoestrogenism from hypogonadism or primary ovarian failure, and for the prevention of postmenopausal osteoporosis, with specific limitations on its use for atrophy and osteoporosis.

    • cyproheptadine hydrochloride

      (Cyproheptadine Hydrochloride)
      Rising Pharma Holdings, Inc.
      Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, cold urticaria, dermatographism, ameliorating allergic reactions to blood, and as an adjunctive therapy for anaphylactic reactions after acute management.

    • cyproheptadine hydrochloride

      (Cyproheptadine Hydrochloride)
      Patrin Pharma, Inc.
      Usage: The drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, cold urticaria, dermatographism, and as an adjunctive therapy for anaphylactic reactions after initial treatment with epinephrine and standard measures.

    • cyproheptadine hydrochloride

      (Cyproheptadine Hydrochloride)
      Amneal Pharmaceuticals of New York LLC
      Usage: This drug is indicated for perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, amelioration of allergic reactions to blood, cold urticaria, dermatographism, and as an adjunctive therapy for anaphylactic reactions after initial management.